Article

Pseudoaccommodative IOL achieves excellent near visual acuity

Paris—Visual acuity results from an international multicenter study demonstrate the AcrySof ReSTOR (Alcon Laboratories) apodized diffractive pseudoaccommodative IOL offers excellent near visual acuity that is independent of pupil size and achieved without compromising distance vision, said Thomas Kohnen, MD.

"This pseudoaccommodative IOL preserves the biomaterial benefits of the AcrySof IOL but incorporates the advantages of a diffractive structure design over 3.6 mm of the anterior surface to optimize for pupil independent vision. Focus visual acuity testing results in this study demonstrate both models of the AcrySof ReSTOR demonstrate a broad range of functionality, including functional intermediate vision and excellent near vision at all pupil sizes," Dr. Kohnen said.

The trial was conducted in the United States and countries in the European Union and was a nonmasked, nonrandomized, parallel study of patients undergoing bilateral implantation with the three-piece AcrySof ReSTOR model SA60D3 (n = 440), the newer one-piece AcrySof ReSTOR model MA60D3 (n = 126), or the control monofocal AcrySof model MA60BM (n = 194). All one-piece ReSTOR and monofocal AcrySof IOLs were implanted in U.S. centers.

Extensive visual acuity testing was performed, including standard distance and near testing as well as at intermediate distances of 50, 60, and 70 cm. Both photopic and mesopic lighting conditions were used and testing was performed with best and standard reading distances.

The visual acuity results achieved in the ReSTOR groups were favorable after single eye implantation and improved further with bilateral implantation.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.